IT vs SGMO · P/E 16, rev $6.27B vs rev $57.8M
Gartner Inc (IT) versus Sangamo Therapeutics Inc (SGMO) — a side-by-side from cached financials, not a winner call.
Gartner Inc (IT) is a information technology services company listed on US.
Sangamo Therapeutics Inc (SGMO) is a biotechnology company listed on NASDAQ.
Latest reported IT revenue for 2024-12-31 was $6.27B. Net income was $1.25B. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. IT currently screens at market cap $11.03B and trailing P/E 16.3.
Latest reported SGMO revenue for 2024-12-31 was $57.8M. Net income was -$97.9M. Revenue was down 67.2% from 2023-12-31 to 2024-12-31. SGMO currently screens at market cap $74.6M.
IT currently screens at market cap $11.03B and trailing P/E 16.3. SGMO currently screens at market cap $74.6M.
Not investment advice. Open the IT and SGMO stock pages for the full models.
Not investment advice.